Catalyst Wire Dossier Catalyst Wire Dossier

ALD-101

· Aldagen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALD-101, covering 2014-07-08 to 2014-07-08. Get the full timeline:

Most recent: Clinical Trial Update: ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases [Phase 3]

See pricing